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Campus, London, UKAbstractToscana virus (TOSV) represents a frequent cause of viral
meningitis in the Mediterranean Basin that remains neglected in
neighbouring countries. We report a documented TOSV
meningitis case in a traveller returning from Tuscany to
Switzerland. While routine serological and PCR assays could not
discriminate between TOSV and Sandﬂy fever Naples virus
infection, a high-throughput sequencing performed directly on
the cerebrospinal ﬂuid specimen and analysed with the ezVIR
pipeline provided an unequivocal viral diagnostic. TOSV could be
unequivocally considered as the aetiological agent, proving the
potential of ezVIR to improve standard diagnostics in cases of
infection with uncommon or emerging viruses.
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IDIBAPS, University of Barcelona, Barcelona, SpainIntroductionToscana virus (TOSV, Phlebovirus) causes human infections via
bites from infected phlebotomes [1], leading to central nervous
system (CNS) infections in a minority of cases. The prevalence of
human infection is closely linked to theMediterranean distribution
of the vectors during the warm season [2,3]. Despite documented
evidence of TOSV presence in neighbouring countries, its inves-
tigation remains neglected inmost routine laboratories in Europe.
TOSV infection is usually diagnosed by detection of IgM, although
cross-reactivities of antibodies targeting TOSV and Sandﬂy fever
Naples virus (SFNV, Phlebovirus) can occur [4,5]. Additionally,
diagnostics based on RT-PCR assays are problematic because of
the short period of viraemia and the low viral load in the cere-
brospinal ﬂuid (CSF) during the acute phase [6–8].
Here we report a documented case of TOSV meningitis in a
traveller returning from Tuscany to Switzerland. The patient is
a 61-year-old healthy man admitted in July 2012 to the Emer-
gency Department of the University Hospitals of Geneva,
Switzerland, presenting headache, nausea, photophobia and
phonophobia, and fever up to 38.3°C. Except for nuchal rigidity,
the neurological examination and the cerebral computed to-
mography were normal. Five days earlier the patient had
returned from a 3-week vacation in Tuscany, Italy, where he
noticed sandﬂy bites. His CSF analysis revealed 134 leucocytes/
mm3; including 45% lymphocytes, 43% monocytes and 12%
neutrophils. Direct Gram stain examination was negative,
glucose level was 3 mmol/L (for a 6.7 mmol/L glycaemia) and
the protein level was 0.78 g/L.
Investigations using PCR for herpes simplex virus types 1 and
2, varicella zoster virus, parechovirus and enterovirus were
negative in the CSF specimen, and serological testing showed
no evidence of infection with West Nile virus. The patient was
put on intravenous amoxicillin plus ceftriaxone. Antiviral
therapy was not introduced. Bacterial cultures remained
negative.
A real-time RT-PCR for TOSV was positive in CSF whereas
serum taken 2 days later was TOSV negative. The real-time RT-Clin Microbiol Infect 2015; 21: 387.e1–387.e4
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387.e2 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIPCR used for TOSV detection was an in-house version (see
Supporting information, Table S1) of a previously described
method [9]. Primers and probe were adapted to ensure the
detection of all TOSV sequences available in GenBank, with the
consequence that other members of the same genus like SFNV
species were also detected. Results of indirect immunoﬂuo-
rescent assays (Sandﬂy_fever_virus_IgM/IgG mosaic_I; Euro-
Immun, Lübeck, Germany) on the serum sample were IgM and
IgG positive for TOSV and SFNV for dilutions 1:10, 1:100 and
1:1000. The patient recovered within 5 days.FIG. 1. ezVIR analysis phase-1 report. Plot depicts: (1) the detection of Tosc
(CSF) specimen, (2) for each detected TOSV segment: the per cent genome co
length in base pairs (area of the coloured dot) and the genome size group (gre
are contained in the corresponding table.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectTaken together, routine serological and PCR assays
conﬁrmed the presence of a phlebovirus genus member in this
meningitis case, but the species identiﬁcation remained
inconclusive. Although TOSV was the most likely candidate, an
SFNV infection could not be ruled out. Due to the low viral
load detected in the positive CSF specimen, both inoculation
on susceptible cell lines such as Vero, SW13, BHK-21 or CV-1
and virus typing by classical PCR-based sequencing approaches
could not be considered. Furthermore, cloning real-time RT-
PCR amplicons was not successful. Hence, high-throughputana virus (TOSV) L- and S-segment sequences in the cerebrospinal ﬂuid
verage (x-axis), the maximum coverage depth (y-axis), the total covered
y outer ring). More details, including the cross-referenced segment IDs,
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 387.e1–387.e4
TABLE 1. Characteristics of Toscana virus meningitis cases in Swiss travellers




PCR (in CSF) Outcome Ref.
1 Elba island ~20 M 10–15 + + − Recovered within 3 days 12
2 Elba island 17 M 14 + + + Recovered within 5 days 4
3 Tuscany 61 M 6–21 + + + Recovered within 5 days This study
CMI Cordey et al. Identiﬁcation of a Toscana virus meningitis case using ezVIR 387.e3sequencing (HTS) technology could be considered in this
situation.
We recently developed a bioinformatic pipeline (ezVIR)
that processes HTS data from any of the standard platforms,
screens all known human viruses, and provides easy to
interpret virus diagnostic results [10]. ezVIR provides HTS
results in two phases: phase 1 provides a rapid identiﬁcation
of the best-scoring viruses present in the specimen analysed
and the optional phase-2 stage provides both virus typing and
genome coverage statistics for any viruses detected in phase
1. Importantly, the pipeline is designed to not only detect
viruses most often analysed in daily practice, but also any
documented human virus including uncommon and emerging
viruses. Therefore, to provide a complete viral diagnostic
result for the case presented here, HTS analysis (paired-end
sequencing using the 100-bp protocol with indexing on a
HiSeq 2500; Illumina, San Diego, CA, USA) was performed
directly on the CSF specimen and analysed using the ezVIR
pipeline as previously described [10]. The ezVIR phase-1
report detected the presence of TOSV in the CSF specimen
analysed (Fig. 1). Reads mapping speciﬁcally to the L- and S-
segments of TOSV genome were observed, but no reads
mapped to SFNV reference sequences. Therefore, TOSV can
be unequivocally considered as the aetiological agent
responsible for the meningitis case depicted here, ruling out a
potential SFNV infection. Notably, the ezVIR database con-
sists of all complete mammalian and avian virus genome se-
quences publicly available (>11 000 full-length genome
sequences). While the ezVIR phase-1 and phase-2 reports
suggest that the specimen contains TOSV genotype A (Fig. 1,
corresponding table), the phase-2 genotyping analysis is based
on the limited number and diversity of TOSV sequences
currently available (36 sequences), and therefore should be
considered with caution.
As mentioned above, in Mediterranean countries TOSV
represents a frequent cause of CNS infection during the summer
season, whereas beyond the endemic area such infections
remain largely neglected. In Switzerland only two cases of TOSV
meningitis were previously described, both from travellers
returning from Elba Island (Table 1). Importantly, although
serological analyses gave positive IgM titres in both cases, onlyClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Incase 2 could be conﬁrmed by a positive real-time RT-PCR
(Table 1), enabling clinicians to rule out any potential serological
cross-reactivities. The TOSV infection documented in this study
conﬁrms the importance for clinicians to be aware of the pos-
sibility of infection with this emerging virus in patients returning
from endemic areas, especially from Italy [4,11,12], Spain
[13,14], France [2,15], Portugal [16], Croatia, Slovenia, Turkey
[17], Greece, Algeria, Malta, Cyprus and Tunisia [2,5,6,18–20].
Although sensitivity and speciﬁcity represent parameters of
utmost importance for the reliability of interpreting diagnostic
assays in routine practice, both are frequently not optimal for
tests dedicated to rare or emerging viruses. Indeed, for such
viruses, molecular or serological assays are frequently either
not available or not speciﬁcally adapted to novel identiﬁed
circulating strains/genotypes, frequently leading to inconclusive
interpretations. This TOSV infection perfectly exempliﬁes this
lack of speciﬁc diagnostic assays for routine screening. There-
fore, analysis of HTS data using pipelines such as ezVIR cir-
cumvents the need to establish and validate an assay that is time
consuming and requires frequent updates and quality checks
according to the novel sequences available. Here, the use of the
ezVIR pipeline enabled TOSV detection directly from the CSF
specimen, demonstrating the capacity of this pipeline to rapidly
provide an unequivocal result interpretation whereas all those
obtained by classical serological and molecular routine assays
remained incomplete or inconclusive. These results and the
ease of their interpretation prove the utility and the potential of
ezVIR to improve standard diagnostics in cases of infections
with emerging viruses.Transparency declarationNo conﬂict of interestAcknowledgementsThe authors would like to thank Brice Petit (University of
Geneva Medical School and Genomics Platform, Geneva,
Switzerland) for technical assistance. This study was supportedfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 387.e1–387.e4
387.e4 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIby the Swiss National Science Foundation (grant
32003B_146993 to L.K.), the Clinical Research Centre, Uni-
versity Hospital and Faculty of Medicine, Geneva and the Louis-
Jeantet Foundation, Subside CRC-Louis-Jeantet recherche
translationnelle 2012 (L.K., E.M.Z. and S.C.).Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.cmi.2014.11.010.References[1] Charrel RN, Bichaud L, de Lamballerie X. Emergence of Toscana virus
in the Mediterranean area. World J Virol 2012;1:135–41.
[2] Charrel RN, Gallian P, Navarro-Mari JM, Nicoletti L, Papa A, Sánchez-
Seco MP, et al. Emergence of Toscana virus in Europe. Emerg Infect Dis
2005;11:1657–63.
[3] Valassina M, Cusi MG, Valensin PE. A Mediterranean arbovirus: the
Toscana virus. J Neurovirol 2003;9:577–83.
[4] Gabriel M, Resch C, Gunther S, Schmidt-Chanasit J. Toscana virus
infection imported from Elba into Switzerland. Emerg Infect Dis
2010;16:1034–6.
[5] Schultze D, Korte W, Rafeiner P, Niedrig M. First report of sandﬂy
fever virus infection imported from Malta into Switzerland, October
2011. Euro Surveill 2012;17:20209.
[6] Depaquit J, Grandadam M, Fouque F, Andry PE, Peyreﬁtte C.
Arthropod-borne viruses transmitted by Phlebotomine sandﬂies in
Europe: a review. Euro Surveill 2010;15:19507.
[7] Dionisio D, Esperti F, Vivarelli A, Valassina M. Epidemiological, clinical
and laboratory aspects of sandﬂy fever. Curr Opin Infect Dis 2003;16:
383–8.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect[8] Tesh RB, Duboise SM. Viremia and immune response with sequential
phlebovirus infections. Am J Trop Med Hyg 1987;36:662–8.
[9] Perez-Ruiz M, Collao X, Navarro-Mari JM, Tenorio A. Reverse tran-
scription, real-time PCR assay for detection of Toscana virus. J Clin
Virol 2007;39:276–81.
[10] Petty TJ, Cordey S, Padioleau I, Docquier M, Turin L, Preynat-
Seauve O, et al. Comprehensive human virus screening using high-
throughput sequencing with a user-friendly representation of bioin-
formatics analysis: a pilot study. J Clin Microbiol 2014;52:3351–61.
[11] Endris RG, Perkins PV. Transmission of Toscana virus by sandﬂies in
Italy. Lancet 1987;1:808–9.
[12] Sonderegger B, Hachler H, Dobler G, Frei M. Imported aseptic men-
ingitis due to Toscana virus acquired on the island of Elba, Italy, August
2008. Euro Surveill 2009;14:19079.
[13] Mendoza-Montero J, Gamez-Rueda MI, Navarro-Mari JM, Rosa-
Fraile M, Oyonarte-Gomez S. Infections due to sandﬂy fever virus
serotype Toscana in Spain. Clin Infect Dis 1998;27:434–6.
[14] Sanbonmatsu-Gamez S, Perez-Ruiz M, Collao X, Sanchez-Seco MP,
Morillas-Marquez F, de la Rosa-Fraile M, et al. Toscana virus in Spain.
Emerg Infect Dis 2005;11:1701–7.
[15] Peyreﬁtte CN, Devetakov I, Pastorino B, Villeneuve L, Bessaud M,
Stolidi P, et al. Toscana virus and acute meningitis, France. Emerg Infect
Dis 2005;11:778–80.
[16] Ehrnst A, Peters CJ, Niklasson B, Svedmyr A, Holmgren B. Neuro-
virulent Toscana virus (a sandﬂy fever virus) in Swedish man after visit
to Portugal. Lancet 1985;1:1212–3.
[17] Ergunay K, Aydogan S, Ilhami OO, Ozcebe O, Cilek EE, Hacioglu S,
et al. Toscana virus (TOSV) exposure is conﬁrmed in blood donors
from Central, North and South/Southeast Anatolia, Turkey. Zoonoses
Public Health 2012;59:148–54.
[18] Eitrem R, Vene S, Niklasson B. Incidence of sand ﬂy fever among
Swedish United Nations soldiers on Cyprus during 1985. Am J Trop
Med Hyg 1990;43:207–11.
[19] Fezaa O, Bahri O, Alaya Bouaﬁf NB, Triki H, Bouattour A. Seropre-
valence of Toscana virus infection in Tunisia. Int J Infect Dis 2013;17:
e1172–5.
[20] Schwarz TF, Gilch S, Jager G. Travel-related Toscana virus infection.
Lancet 1993;342:803–4.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 387.e1–387.e4
